Trial intelligence / Profile preview

MOUNTAIN-PAIN: Methoxyflurane for Pain at High Altitude

NCT03849027Phase 4Unknown

Sponsor
University of Cape Town
Start
May 2019
Primary completion
Sep 2019
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of methoxyflurane in pain (2 arms), sponsored by University of Cape Town. Primary endpoint: Analgesic effect at 3 weeks. Status: unknown.

02

Drugs

methoxyflurane
03

Conditions

pain

Beyond the preview

Go deeper on NCT03849027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03849027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call